Boston Scientific (NYSE:BSX) has joined in on a $23.1 million Series B round for cardiovascular neuromod company NeuroTronik. The Durham, N.C.-based company said that BSX led the round and was joined by Hatteras Venture Partners, Synergy Life Science Partners, Lord Baltimore Investment Partners, Mountain Group Capital and Sovereign’s Capital. NeuroTronik is developing a novel neuromodulation device […]
NeuroTronik
North Carolina startup NeuroTronik seeks $3.3M
North Carolina neuromodulation startup NeuroTronik is halfway to its $3.3 million goal in an equity funding round launched May 31, 2013.
NeuroTronik, which about a year ago spun out of business accelerator Synecor, is working on a neuromodulation system that may be an alternative to invasive defibrillators for treating patients with heart failure.